Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19
Liusheng Wu(Anhui Medical University), Xiaoqiang Li(Chinese Academy of Sciences), Ruixing Luo(Peking University Shenzhen Hospital), Pengcheng Xu(Peking University Shenzhen Hospital), Dingwang Wu(Peking University Shenzhen Hospital), Da Wu(Anhui Medical University), Jixian Liu(Dongguan University of Technology), Yuzhen Zheng(Sixth Affiliated Hospital of Sun Yat-sen University)
Cited by 115
Related Papers
Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis
|Biomedicines|2022|121
Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research
|Anti-Cancer Drugs|2022|120
Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
|Biomedicines|2023|112
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
|Vaccines|2024|106
Research progress of 3D-bioprinted functional pancreas and in vitro tumor models
|International Journal of Bioprinting|2024|71